The liver transplant team at Zhongshan Hospital, affiliated with Fudan University, is renowned for outstanding clinical expertise, with an annual surgical volume ranking among the world's highest. Over the years, the hospital has helped numerous patients with end-stage liver disease gain a new lease on life, maintaining high long-term survival rates and becoming one of Asia's most important liver transplant centers.
Technical strength and surgical volume
The liver transplant center at Zhongshan Hospital has an experienced surgical team and a well-established multidisciplinary collaboration system. From preoperative evaluation, donor liver procurement and transplant surgery to postoperative immunosuppression management, the hospital has established a standardized full-process management pathway. Its annual liver transplant volume ranks among the highest in China and globally, with surgical success rates and patient survival reaching internationally advanced levels.
For patients awaiting transplantation, shorter waiting times, fewer complications and better long-term quality of life are the core indicators of a transplant center's strength, and Zhongshan performs strongly on all of them.
Who may benefit
Liver transplantation mainly applies to end-stage cirrhosis, fulminant hepatic failure, and hepatocellular carcinoma with cirrhosis. Not every liver disease patient needs a transplant; whether and when to transplant must be decided by a multidisciplinary team evaluation.
Information for international patients
International patients considering a liver transplant at Zhongshan should first submit complete medical records and imaging data for remote evaluation by the hospital's expert team. Liver transplantation involves organ sources, ethical review and legal procedures, and patients should go through formal channels to understand and handle the relevant procedures.
MedBridge services
MedBridge can connect international patients with the liver transplant center at Zhongshan Hospital, providing medical record translation, expert remote evaluation appointments, arrangements for treatment in Shanghai and postoperative follow-up support.